Hemogenyx Pharmaceuticals (UK) Probability of Future Stock Price Finishing Over 343.40
| HEMO Stock | 343.40 20.90 6.48% |
Hemogenyx |
Hemogenyx Pharmaceuticals Target Price Odds to finish over 343.40
The tendency of Hemogenyx Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 343.40 | 90 days | 343.40 | roughly 97.0 |
Based on a normal probability distribution, the odds of Hemogenyx Pharmaceuticals to move above the current price in 90 days from now is roughly 97.0 (This Hemogenyx Pharmaceuticals PLC probability density function shows the probability of Hemogenyx Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Hemogenyx Pharmaceuticals PLC has a beta of -1.19. This usually indicates as returns on its benchmark rise, returns on holding Hemogenyx Pharmaceuticals PLC are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Hemogenyx Pharmaceuticals is expected to outperform its benchmark. Additionally Hemogenyx Pharmaceuticals PLC has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Hemogenyx Pharmaceuticals Price Density |
| Price |
Predictive Modules for Hemogenyx Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Hemogenyx Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Hemogenyx Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Hemogenyx Pharmaceuticals is not an exception. The market had few large corrections towards the Hemogenyx Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Hemogenyx Pharmaceuticals PLC, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Hemogenyx Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.48 | |
β | Beta against Dow Jones | -1.19 | |
σ | Overall volatility | 86.37 | |
Ir | Information ratio | -0.07 |
Hemogenyx Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Hemogenyx Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Hemogenyx Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Hemogenyx Pharmaceuticals generated a negative expected return over the last 90 days | |
| Hemogenyx Pharmaceuticals has high historical volatility and very poor performance | |
| Net Loss for the year was (6.69 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Hemogenyx Pharmaceuticals generates negative cash flow from operations | |
| Latest headline from news.google.com: Hemogenyx Pharmaceuticals Sets New 12-Month Low - Heres What Happened - MarketBeat |
Hemogenyx Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Hemogenyx Stock often depends not only on the future outlook of the current and potential Hemogenyx Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Hemogenyx Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.1 B | |
| Cash And Short Term Investments | 1.2 M |
Hemogenyx Pharmaceuticals Technical Analysis
Hemogenyx Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Hemogenyx Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Hemogenyx Pharmaceuticals PLC. In general, you should focus on analyzing Hemogenyx Stock price patterns and their correlations with different microeconomic environments and drivers.
Hemogenyx Pharmaceuticals Predictive Forecast Models
Hemogenyx Pharmaceuticals' time-series forecasting models is one of many Hemogenyx Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Hemogenyx Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Hemogenyx Pharmaceuticals
Checking the ongoing alerts about Hemogenyx Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Hemogenyx Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Hemogenyx Pharmaceuticals generated a negative expected return over the last 90 days | |
| Hemogenyx Pharmaceuticals has high historical volatility and very poor performance | |
| Net Loss for the year was (6.69 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Hemogenyx Pharmaceuticals generates negative cash flow from operations | |
| Latest headline from news.google.com: Hemogenyx Pharmaceuticals Sets New 12-Month Low - Heres What Happened - MarketBeat |
Additional Tools for Hemogenyx Stock Analysis
When running Hemogenyx Pharmaceuticals' price analysis, check to measure Hemogenyx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemogenyx Pharmaceuticals is operating at the current time. Most of Hemogenyx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hemogenyx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemogenyx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hemogenyx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.